Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | |
---|---|---|---|
A Phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) Proceeding/Conference:Journal of Hepatology | 2011 |